These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 24827032)

  • 1. Responding to hepatitis C through the criminal justice system.
    Rich JD; Allen SA; Williams BA
    N Engl J Med; 2014 May; 370(20):1871-4. PubMed ID: 24827032
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatitis C in the criminal justice system: opportunities for global action in the era of viral hepatitis elimination.
    Akiyama MJ
    BMC Med; 2020 Aug; 18(1):208. PubMed ID: 32792001
    [No Abstract]   [Full Text] [Related]  

  • 3. Sofosbuvir, simeprevir, and ribavirin for the treatment of hepatitis C virus recurrence in human immunodeficiency virus/hepatitis C virus-coinfected liver transplant recipients.
    Campos-Varela I; Straley S; Agudelo EZ; Carlson L; Terrault NA
    Liver Transpl; 2015 Feb; 21(2):272-4. PubMed ID: 25332190
    [No Abstract]   [Full Text] [Related]  

  • 4. Simeprevir for the treatment of hepatitis C and HIV/hepatitis C co-infection.
    Flanagan S; Crawford-Jones A; Orkin C
    Expert Rev Clin Pharmacol; 2014 Nov; 7(6):691-704. PubMed ID: 25209158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simeprevir plus sofosbuvir, with or without ribavirin, to treat chronic infection with hepatitis C virus genotype 1 in non-responders to pegylated interferon and ribavirin and treatment-naive patients: the COSMOS randomised study.
    Lawitz E; Sulkowski MS; Ghalib R; Rodriguez-Torres M; Younossi ZM; Corregidor A; DeJesus E; Pearlman B; Rabinovitz M; Gitlin N; Lim JK; Pockros PJ; Scott JD; Fevery B; Lambrecht T; Ouwerkerk-Mahadevan S; Callewaert K; Symonds WT; Picchio G; Lindsay KL; Beumont M; Jacobson IM
    Lancet; 2014 Nov; 384(9956):1756-65. PubMed ID: 25078309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Efficacy of On-Site Integration Screening and Microelimination Programs for Chronic Hepatitis C in a Detection Center: A Comparison of the Treatment Outcomes and Characteristics of Incarcerated Patients and Outpatients.
    Chang HY; Wang SH; Kuo HT; Sheu MJ; Feng IC; Ho CH; Chen JY; Sun CS; Chen CH; Lin CY; Yang CC
    Int J Hepatol; 2024; 2024():3184892. PubMed ID: 38510786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in HCV Seroprevalence, Clinical Features, and Treatment Outcomes between Female and Male Incarcerated Population: Results from a Matched Cohort Study.
    Fiore V; De Vito A; Rastrelli E; Manca V; De Matteis G; Ranieri R; Pontali E; Geremia N; Panese S; Starnini G; Madeddu G; Babudieri S
    Viruses; 2023 Dec; 15(12):. PubMed ID: 38140655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis C prevalence in incarcerated settings between 2013-2021: a systematic review and meta-analysis.
    Busschots D; Kremer C; Bielen R; Koc ÖM; Heyens L; Nevens F; Hens N; Robaeys G
    BMC Public Health; 2022 Nov; 22(1):2159. PubMed ID: 36419013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A retrospective, descriptive study of hepatitis C testing, prevalence, and care continuum among adults on probation.
    Kamis KF; Wyles DL; Minturn MS; Scott T; McEwen D; Hurley H; Prendergast SJ; Gunter J; Rowan SE
    Health Justice; 2022 Aug; 10(1):26. PubMed ID: 35947313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HCV spread among female incarcerated population and treatment pathways to viral elimination in Italian prison settings: clinical perspectives and medico legal aspects.
    Fiore V; Rastrelli E; Madeddu G; Ranieri R; De Vito A; Giuliani R; Di Mizio G; Bolcato M; De Matteis G; Ialungo AM; Dell'Isola S; Starnini G; Babudieri S
    BMC Infect Dis; 2022 Jul; 22(1):601. PubMed ID: 35799126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Importance of Prisons in Achieving Hepatitis C Elimination: Insights from the Australian Experience.
    Winter RJ; Holmes JA; Papaluca TJ; Thompson AJ
    Viruses; 2022 Feb; 14(3):. PubMed ID: 35336905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of Hepatitis C in Delaware Prisons: : Approaching Microenvironmental Eradication.
    Mazur WP
    Dela J Public Health; 2019 May; 5(2):20-27. PubMed ID: 34467026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multicentre interventional study to assess blood-borne viral infections in Belgian prisons.
    Busschots D; Kremer C; Bielen R; Koc ÖM; Heyens L; Brixko C; Laukens P; Orlent H; Bilaey P; De Smet F; Hellemans G; Muyldermans G; Van Baelen L; Hens N; Van Vlierberghe H; Robaeys G
    BMC Infect Dis; 2021 Jul; 21(1):708. PubMed ID: 34315415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of Universal and Targeted Hepatitis C Virus Screening in the United States.
    Tatar M; Keeshin SW; Mailliard M; Wilson FA
    JAMA Netw Open; 2020 Sep; 3(9):e2015756. PubMed ID: 32880650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An evaluation of the hepatitis C testing, care and treatment program in the country of Georgia's corrections system, December 2013 - April 2015.
    Harris AM; Chokoshvili O; Biddle J; Turashvili K; Japaridze M; Burjanadze I; Tsertsvadze T; Sharvadze L; Karchava M; Talakvadze A; Chakhnashvili K; Demurishvili T; Sabelashvili P; Foster M; Hagan L; Butsashvili M; Morgan J; Averhoff F
    BMC Public Health; 2019 May; 19(Suppl 3):466. PubMed ID: 32326938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Linkage to hepatitis C care after incarceration in jail: a prospective, single arm clinical trial.
    Akiyama MJ; Columbus D; MacDonald R; Jordan AO; Schwartz J; Litwin AH; Eckhardt B; Carmody E
    BMC Infect Dis; 2019 Aug; 19(1):703. PubMed ID: 31395019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences by sex in associations between injection drug risks and drug crime conviction among people who inject drugs in Almaty, Kazakhstan.
    Marotta PL; Gilbert L; Terlikbayeva A; Wu E; El-Bassel N
    Int J Drug Policy; 2018 Oct; 60():96-106. PubMed ID: 30219718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C Guidance 2018 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection.
    AASLD-IDSA HCV Guidance Panel
    Clin Infect Dis; 2018 Oct; 67(10):1477-1492. PubMed ID: 30215672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug Purchasing Strategies to Treat People With Hepatitis C in the Criminal Justice System.
    Akiyama MJ; Feffer R; von Oehsen WH; Litwin AH
    Am J Public Health; 2018 May; 108(5):607-608. PubMed ID: 29617597
    [No Abstract]   [Full Text] [Related]  

  • 20. Six-Month Emergency Department Use among Older Adults Following Jail Incarceration.
    Humphreys J; Ahalt C; Stijacic-Cenzer I; Widera E; Williams B
    J Urban Health; 2018 Aug; 95(4):523-533. PubMed ID: 29204845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.